1h Free Analyst Time
Global Prostate Biopsy Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the prostate biopsy market and it is poised to grow by $ 380.23 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The reports on the prostate biopsy market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing incidences of prostate cancer and the growing number of diagnostic centers. In addition, growing incidences of prostate cancer is anticipated to boost the growth of the market as well.
The prostate biopsy market analysis includes product segment and geographical landscapes.
The prostate biopsy market is segmented as below:
By Product
- Prostate needle biopsy
- Prostate liquid biopsy
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the recurrent revenue from repeat biopsy tests as one of the prime reasons driving the prostate biopsy market growth during the next few years.
The prostate biopsy market report covers the following areas:
- Prostate biopsy market sizing
- Prostate biopsy market forecast
- Prostate biopsy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading prostate biopsy market vendors that include Becton, Dickinson and Co., Bio-Techne Corp., Boston Scientific Corp., Cook Group Inc., F. Hoffmann-La Roche Ltd., Guardant Health Inc., PURE Medical Device SA, QIAGEN NV, SOMATEX Medical Technologies GmbH, and Thermo Fisher Scientific Inc. Also, the prostate biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by End user
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the global prostate biopsy market: Becton, Dickinson and Co., Bio-Techne Corp., Boston Scientific Corp., Cook Group Inc., F. Hoffmann-La Roche Ltd., Guardant Health Inc., PURE Medical Device SA, QIAGEN NV, SOMATEX Medical Technologies GmbH, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is recurrent revenue from repeat biopsy tests.'
According to the report, one of the major drivers for this market is the growing incidences of prostate cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton
- Dickinson and Co.
- Bio-Techne Corp.
- Boston Scientific Corp.
- Cook Group Inc.
- F. Hoffmann-La Roche Ltd.
- Guardant Health Inc.
- PURE Medical Device SA
- QIAGEN NV
- SOMATEX Medical Technologies GmbH
- Thermo Fisher Scientific Inc.
